Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIVITROL for prevention of re-arrest in opioid-dependent inmates
NCT01453374Phase 4Completed
- Sponsor
- Alkermes
- Start
- Jan 2011
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in opioid use disorder (OUD), sponsored by Alkermes. Started Jan 2011; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01453374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01453374.